Condition
Extensive Stage Lung Small Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Extensive Stage Lung Small Cell Carcinoma clinical trials that are recruiting, in United States. By phase: Phase 2 (4), Phase 1/2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1Country
Newest Extensive Stage Lung Small Cell Carcinoma clinical trials
All recruiting trials (7)
-
Tarlatamab treatment for extensive-stage small cell lung cancer
This phase II trial tests tarlatamab, a bispecific antibody, to see if it helps adults with extensive-stage small cell lung cancer live longer and delay tumor growth.
-
Biomarker-guided personalized maintenance treatments for extensive-stage small cell lung cancer
This phase II trial tests whether biomarker tests on a patient's tumor can guide personalized maintenance drug combinations for people with extensive-stage small cell lung cancer.
-
Combining iadademstat with immunotherapy for advanced small cell lung cancer
This study is testing whether adding a new drug called iadademstat to standard immunotherapy can help people with advanced small cell lung cancer live longer without their disease getting worse.
-
Combining total body irradiation with chemotherapy and immunotherapy for extensive stage lung cancer
This study is testing if adding total body radiation to standard chemotherapy and immunotherapy can help people with advanced small cell lung cancer live longer and feel better.
-
Combining palliative radiotherapy with lurbinectedin for extensive stage small cell lung cancer
This study is testing if combining palliative radiotherapy with the drug lurbinectedin can help people with advanced small cell lung cancer feel better after their chemotherapy has stopped working.
-
Using temozolomide and atezolizumab for advanced small cell lung cancer
This study is testing if a combination of two drugs, temozolomide and atezolizumab, can help people with advanced small cell lung cancer live longer and feel better.
-
Using lamivudine with chemoimmunotherapy for extensive stage small cell lung cancer
This study is testing if adding lamivudine to standard chemoimmunotherapy can help people with extensive stage small cell lung cancer live longer and stay cancer-free for longer.
Related topics
Quick answers
How many Extensive Stage Lung Small Cell Carcinoma clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.